-+ 0.00%
-+ 0.00%
-+ 0.00%

LIGAND PHARMACEUTICALS INCORPORATED : STIFEL RAISES TARGET PRICE TO $350 FROM $332

Reuters·10/30/2026 11:20:57

Please log in to view news